Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Interleukin 28 B genotype as a predictor of response to therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Study of insulin resistance (IR) as a predictor for response to interferon based therapy in patients with chronic HCV

Correlation between lipid profile and rapid virological response to treatment of hepatitis C virus genotype IV with pegylated interferon alpha and ribavirin

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Single nucleotide polymorphism (SNP) rs8099917 as a predictive factor of virological response to pegylated interferon plus Ribavirin in treatment of chronic hepatitis c virus patients

Evaluation of different laboratory tests as predictors to the response for interferon therapy in chronic hepatitis c virus patients

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment